186 related articles for article (PubMed ID: 10796055)
1. Gastroprotective effects of pantoprazole against experimental mucosal damage.
Blandizzi C; Natale G; Gherardi G; Lazzeri G; Marveggio C; Colucci R; Carignani D; Del Tacca M
Fundam Clin Pharmacol; 2000; 14(2):89-99. PubMed ID: 10796055
[TBL] [Abstract][Full Text] [Related]
2. Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury.
Blandizzi C; Natale G; Gherardi G; Lazzeri G; Marveggio C; Colucci R; Carignani D; Del Tacca M
Dig Dis Sci; 1999 Oct; 44(10):2039-50. PubMed ID: 10548356
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage.
Fornai M; Natale G; Colucci R; Tuccori M; Carazzina G; Antonioli L; Baldi S; Lubrano V; Abramo A; Blandizzi C; Del Tacca M
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):79-87. PubMed ID: 16080005
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds.
Natale G; Lazzeri G; Lubrano V; Colucci R; Vassalle C; Fornai M; Blandizzi C; Del Tacca M
Toxicol Appl Pharmacol; 2004 Feb; 195(1):62-72. PubMed ID: 14962506
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of protection by omeprazole against experimental gastric mucosal damage in rats.
Blandizzi C; Gherardi G; Marveggio C; Natale G; Carignani D; Del Tacca M
Digestion; 1995; 56(3):220-9. PubMed ID: 7657048
[TBL] [Abstract][Full Text] [Related]
6. Cytoprotective effects of NC-1300 and omeprazole on Hcl . ethanol-induced gastric lesions in rats.
Okabe S; Miyake H; Awane Y
Jpn J Pharmacol; 1986 Sep; 42(1):123-33. PubMed ID: 3795613
[TBL] [Abstract][Full Text] [Related]
7. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
[TBL] [Abstract][Full Text] [Related]
8. Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage.
Blandizzi C; Fornai M; Colucci R; Natale G; Lubrano V; Vassalle C; Antonioli L; Lazzeri G; Del Tacca M
World J Gastroenterol; 2005 Jul; 11(26):4052-60. PubMed ID: 15996031
[TBL] [Abstract][Full Text] [Related]
9. Pantoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion.
Dammann HG; Burkhardt F
Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1277-82. PubMed ID: 10563540
[TBL] [Abstract][Full Text] [Related]
10. Effects of pantoprazole, a novel H+/K+-ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: a comparative study with omeprazole and lansoprazole.
Takeuchi K; Konaka A; Nishijima M; Kato S; Yasuhiro T
J Gastroenterol Hepatol; 1999 Mar; 14(3):251-7. PubMed ID: 10197495
[TBL] [Abstract][Full Text] [Related]
11. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.
Blandizzi C; Lazzeri G; Colucci R; Carignani D; Tognetti M; Baschiera F; Del Tacca M
Eur J Pharmacol; 1999 May; 373(1):71-84. PubMed ID: 10408253
[TBL] [Abstract][Full Text] [Related]
12. Study of Mimusops elengi bark in experimental gastric ulcers.
Shah PJ; Gandhi MS; Shah MB; Goswami SS; Santani D
J Ethnopharmacol; 2003 Dec; 89(2-3):305-11. PubMed ID: 14611897
[TBL] [Abstract][Full Text] [Related]
13. SU-840, a novel synthetic flavonoid derivative of sophoradin, with potent gastroprotective and ulcer healing activity.
Brzozowski T; Konturek SJ; Kwiecien S; Pajdo R; Drozdowicz D; Sliwowski Z; Muramatsu M
J Physiol Pharmacol; 1998 Mar; 49(1):83-98. PubMed ID: 9594413
[TBL] [Abstract][Full Text] [Related]
14. Gastroprotective and anti-secretory mechanisms of 2-phenylquinoline, an alkaloid isolated from Galipea longiflora.
Breviglieri E; Mota da Silva L; Boeing T; Somensi LB; Cury BJ; Gimenez A; Cechinel Filho V; de Andrade SF
Phytomedicine; 2017 Feb; 25():61-70. PubMed ID: 28190472
[TBL] [Abstract][Full Text] [Related]
15. Cytoprotective effect of rabeprazole against ethanol-induced gastric mucosal damage: possible involvement of nitric oxide.
Watanabe T; Higuchi K; Tominaga K; Fujiwara Y; Arakawa T
Drugs Exp Clin Res; 2000; 26(2):41-5. PubMed ID: 10894554
[TBL] [Abstract][Full Text] [Related]
16. Gastric antisecretory and antiulcer activity of bovine hemoglobin.
Al Asmari AK; Al Omani S; Elfaki I; Tariq M; Al Malki A; Al Asmary S
World J Gastroenterol; 2013 Jun; 19(21):3291-9. PubMed ID: 23745031
[TBL] [Abstract][Full Text] [Related]
17. Correlation between acid secretion and proton pump activity during inhibition by the proton pump inhibitors omeprazole and pantoprazole.
Nishioka K; Nagao T; Urushidani T
Biochem Pharmacol; 1999 Oct; 58(8):1349-59. PubMed ID: 10487539
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults.
Pratha VS; Hogan DL; Lane JR; Williams PJ; Burton MS; Lynn RB; Karlstadt RG
Dig Dis Sci; 2006 Jan; 51(1):123-31. PubMed ID: 16416224
[TBL] [Abstract][Full Text] [Related]
19. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
Makovec F; Revel L; Letari O; Mennuni L; Impicciatore M
Eur J Pharmacol; 1999 Mar; 369(1):81-90. PubMed ID: 10204685
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats.
Kim KB; Chang MS; Chung YK; Sohn SK; Kim SG; Choi WS
J Pharm Pharmacol; 1998 May; 50(5):521-9. PubMed ID: 9643446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
